首页> 外文期刊>Vaccine >Identification of proteins of Propionibacterium acnes for use as vaccine candidates to prevent infection by the pig pathogen Actinobacillus pleuropneumoniae.
【24h】

Identification of proteins of Propionibacterium acnes for use as vaccine candidates to prevent infection by the pig pathogen Actinobacillus pleuropneumoniae.

机译:鉴定痤疮丙酸杆菌的蛋白质,以用作预防猪病原体胸膜肺炎放线杆菌感染的候选疫苗。

获取原文
获取原文并翻译 | 示例
           

摘要

Actinobacillus pleuropneumoniae is the causative agent of acute and chronic pleuroneumonia that is responsible for substantial morbidity and mortality in the pig industry. New improved vaccines that can protect against all serotypes and prevent colonization are required. In a previous study we showed that whole cells of Propionibacterium acnes protected pigs from A. pleuropneumoniae serotype 1 and 5 and, therefore, the basis for a promising heterologous vaccine. The aim of this study was to identify those protein antigens of P. acnes responsible for protection against A. pleuropneumoniae infection. Six P. acnes protein antigens that were recognized by sera raised against A. pleuropneumoniae were identified by 2-DE and immunoblotting. Recombinant versions of all P. acnes proteins gave partial protection (10-80%) against A. pleuropneumoniae serotype 1 and/or 5 infection in a mouse challenge model. The best protection (80% serotype 1; 60% serotype 5) was obtained using recombinant P. acnes single-stranded DNA-binding protein. In part, protection against A. pleuropneumoniae infection may be mediated by small peptide sequences present in P. acnes single-stranded DNA-binding protein that are cross-reactive with those present in the A. pleuropneumoniae-specific RTX toxin ApxIV and the zinc-binding protein ZnuA. The results suggest that P. acnes may be a useful vaccine to protect against different serotypes of A. pleuropneumoniae.
机译:胸膜肺炎放线杆菌是急性和慢性胸膜肺炎的病原体,在养猪业中引起大量发病和死亡。需要能够抵抗所有血清型并防止定植的新型改良疫苗。在先前的研究中,我们表明痤疮丙酸杆菌的整个细胞可以保护猪免受猪肺炎链球菌血清型1和5的侵袭,因此,猪是有前途的异源疫苗的基础。这项研究的目的是确定痤疮丙酸杆菌的那些蛋白抗原,这些蛋白抗原可预防胸膜肺炎链球菌感染。通过2-DE和免疫印迹鉴定了被针对胸膜肺炎链球菌的血清所识别的六个痤疮丙酸杆菌蛋白抗原。在小鼠攻击模型中,所有痤疮丙酸杆菌蛋白的重组形式均提供了针对胸膜肺炎链球菌血清型1和/或5感染的部分保护(10-80%)。使用重组痤疮丙酸杆菌单链DNA结合蛋白可获得最佳保护(80%血清型1; 60%血清型5)。部分地,可以通过痤疮丙酸杆菌单链DNA结合蛋白中存在的小肽序列来介导针对胸膜肺炎链球菌感染的保护,该小肽序列与胸膜肺炎链球菌特异性RTX毒素ApxIV和锌-结合蛋白ZnuA。结果表明痤疮丙酸杆菌可能是预防不同血清型胸膜肺炎放线杆菌的有用疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号